Phathom Pharmaceuticals Inc (NAS:PHAT) Stock News, Headlines & Updates
Phathom Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jun 23, 2025
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PHAT Stock News
GuruFocus News • 3:34pm
Phathom Pharmaceuticals (PHAT) Appoints New Chief Legal Officer | PHAT Stock News
GuruFocus News • 12:21pm
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
Marketwired • 7:00am
Jun 16, 2025
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032 | PHAT Stock News
GuruFocus News • 7:23am
Phathom Pharmaceuticals (PHAT) Secures Extended Exclusivity for VOQUEZNA | PHAT Stock News
GuruFocus News • 7:16am
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
Marketwired • 7:00am
Jun 09, 2025
Phathom Pharmaceuticals (PHAT) Analyst Rating Update: Price Target Raised to $17.00 | PHAT Stock News
GuruFocus News • 10:30am
Phathom Pharmaceuticals (PHAT) Price Target Increased Following FDA Ruling | PHAT Stock News
GuruFocus News • 8:18am
Phathom Pharmaceuticals (PHAT) Receives Buy Rating from HC Wainwright | PHAT Stock News
GuruFocus News • 7:00am
Jun 06, 2025
Phathom Pharmaceuticals (PHAT) Receives Continued Buy Rating from Needham | PHAT Stock News
GuruFocus News • 2:30pm
Phathom Pharmaceuticals (PHAT) Soars on FDA Approval and Market Exclusivity | PHAT Stock News
GuruFocus News • 2:01pm
PHAT Stock Target Raised Amid Extended Drug Exclusivity | PHAT Stock News
GuruFocus News • 12:30pm
FDA Grants Extended Exclusivity to Phathom Pharmaceuticals (PHAT) | PHAT Stock News
GuruFocus News • 12:15pm
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
Marketwired • 12:00pm
Phathom Pharmaceuticals (PHAT) Soars 125% on FDA Decision
GuruFocus News • 11:55am
Phathom Pharmaceuticals (PHAT) Soars Over 120% After FDA Update | PHAT Stock News
GuruFocus News • 11:46am
FDA Grants Phathom Pharmaceuticals (PHAT) Extended Exclusivity for Voquenza | PHAT Stock News
GuruFocus News • 11:45am
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032 | PHAT Stock News
GuruFocus News • 11:45am
May 15, 2025
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Marketwired • 7:00am
May 09, 2025
Phathom Pharmaceuticals (PHAT) Shares Surge After Board Member's Large Purchase
GuruFocus News • 11:57am
Insider Buying: Asit Parikh Acquires Additional Shares of Phathom Pharmaceuticals Inc (PHAT)
GuruFocus News • 9:11pm
May 02, 2025
Phathom Pharmaceuticals (PHAT) Price Target Lowered by Goldman Sachs | PHAT Stock News
GuruFocus News • 12:36pm
Phathom Pharmaceuticals (PHAT) Target Price Lowered by Guggenheim | PHAT Stock News
GuruFocus News • 12:31pm
Phathom Pharmaceuticals (PHAT) Maintains Buy Rating as Price Target Drops | PHAT Stock News
GuruFocus News • 8:37am
Phathom Pharmaceuticals (PHAT) Price Target Reduced by Guggenheim | PHAT Stock News
GuruFocus News • 7:19am
PHAT Faces Price Target Cut Amidst Restructuring Efforts | PHAT Stock News
GuruFocus News • 5:32am
Phathom Pharmaceuticals Inc (PHAT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Adjustments
GuruFocus News • 1:02am
Q1 2025 Phathom Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:16pm
May 01, 2025
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PHAT Stock News
GuruFocus News • 3:46pm
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Marketwired • 7:00am
Phathom (PHAT) Implements Strategic Shift for Long-Term Growth | PHAT Stock News
GuruFocus News • 6:46am
Phathom Pharmaceuticals Q1 2025 Earnings: EPS Matches Estimates at -$1.18, Revenue Falls Short at $28.5 Million
GuruFocus News • 6:35am
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update | PHAT Stock News
GuruFocus News • 6:19am
BlackRock, Inc. Reduces Stake in Phathom Pharmaceuticals Inc.
GuruFocus News • 8:56pm
Apr 28, 2025
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting
Marketwired • 7:00am
Apr 23, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news